Conformational changes of the N-terminal part of Mason-Pfizer monkey virus p12 protein during multimerization

Virology

Volumn 393, Issue 1, 2009, Pages 168-176

  Knejzlík, Zdeněk ^a   Ulbrich, Pavel ^a   Strohalm, Martin ^a,b   Laštůvková, Hana ^a   Kodíček, Milan ^a   Sakalian, Michael ^b,c   Ruml, Tomáš ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Helix; CD spectroscopy; M PMV; Multimerization; p12 protein; Virus assembly

Indexed keywords

PROTEIN P12; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENETIC TRANSCRIPTION AND TRANSLATION; IN VITRO STUDY; MASON PFIZER MONKEY VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STRUCTURE; ULTRACENTRIFUGATION;

CIRCULAR DICHROISM; GENE PRODUCTS, GAG; MASON-PFIZER MONKEY VIRUS; MICROSCOPY, ELECTRON; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; ULTRACENTRIFUGATION;

BETARETROVIRUS; MASON-PFIZER MONKEY VIRUS; PAPAYA MOSAIC VIRUS;

EID: 70349255514     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.07.014     Document Type: Article

References (49)

1. Accola M.A., Strack B., and Göttlinger H.G. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 74 (2000) 5395-5402
2. Amarasinghe G.K., De Guzman R.N., Turner R.B., Chancellor K.J., Wu Z.R., and Summers M.F. NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the C-RNA packaging signal. Implications for genome recognition. J. Mol. Biol. 301 (2000) 491-511
3. Auerbach M.R., Brown K.R., and Singh I.R. Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein. J. Virol. 81 (2007) 12337-12347
4. Borsetti A., Öhagen Ä., and Göttlinger H.G. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. J. Virol. 72 (1998) 9313-9317
5. Bowzard J.B., Bennett R.P., Krishna N.K., Ernst S.M., Rein A., and Wills J.W. Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue. J. Virol. 72 (1998) 9034-9044
6. Bradac J., and Hunter E. Polypeptides of Mason-Pfizer monkey virus. I. Synthesis and processing of the gag-gene products. Virology 138 (1984) 260-275
7. Bryant M., and Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 523-527
8. Campbell S., and Vogt V.M. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 69 (1995) 6487-6497
9. Chatel-Chaix L., Clément J.F., Martel C., Bériault V., Gatignol A., DesGroseillers L., and Mouland A.J. Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles. Mol. Cell. Biol. 24 (2004) 2637-2648
10. Chatel-Chaix L., Abrahamyan L., Fréchina C., Mouland A.J., and DesGroseillers L. The host protein Staufen1 participates in human immunodeficiency virus type 1 assembly in live cells by influencing pr55Gag multimerization. J. Virol. 81 (2007) 216-230
11. Choi G., Park S., Choi B., Hong S., Lee J., Hunter E., and Rhee S.S. Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein. J. Virol. 73 (1999) 5431-5437
12. Chukkapalli V., Hogue I.B., Boyko V., Hu W.-S., and Ono A. Interaction between the human immunodeficiency virus type 1 gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient Gag membrane binding. J. Virol. 82 (2008) 2405-2417
13. D'Souza V., and Summers M.F. Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus. Nature 431 (2004) 586-590
14. Dalton A.K., Murray P.S., Murray D., and Vogt V.M. Biochemical characterization of Rous sarcoma virus MA protein interaction with membranes. J. Virol. 79 (2005) 6227-6238
15. Dalton A.K., Ako-Adjei D., Murray P.S., Murray D., and Vogt V.M. Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain. J. Virol. 81 (2007) 6434-6445
16. Datta S.A., Zhao Z., Clark P.K., Tarasov S., Alexandratos J.N., Campbell S.J., Kvaratskhelia M., Lebowitz J., and Rein A. Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J. Mol. Biol. 365 (2007) 799-811
17. Dong X., Li H., Derdowski A., Ding L., Burnett A., Chen X., Peters T.R., Dermody T.S., Woodruff E., Wang J.J., and Spearman P. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell 120 (2005) 663-674
18. Dorfman T., Popova E., Pizzato M., and Göttlinger H.G. Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix. J. Virol. 2002 76 (2002) 6857-6862
19. Ganser-Pornillos B.K., Yeager M., and Sundquist W.I. The structural biology of HIV assembly. Curr. Opin. Struct. Biol. 18 (2008) 203-217
20. Gross I., Hohenburg H., and Kräusslich H.G. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. Eur. J. Biochem. 249 (1997) 592-600
21. Joshi A., Nagashima K., and Freed E.O. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation. J. Virol. 80 (2006) 7939-7951
22. Knejzlík Z., Strohalm M., Sedláčková L., Kodícek M., Sakalian M., and Ruml T. Isolation and characterization of the Mason-Pfizer monkey virus p12 protein. Virology. 324 (2004) 204-212
23. Knejzlík Z., Smékalová Z., Ruml T., and Sakalian M. Multimerization of the p12 domain is necessary for Mason-Pfizer monkey virus Gag assembly in vitro. Virology. 365 (2007) 260-270
24. Lanman J., Lam T.T., Emmett M.R., Marshall A.G., Sakalian M., and Prevelige Jr. P.E. Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange. Nat. Struct. Mol. Biol. 11 (2004) 676-677
25. Lee P.P., and Pinkal M.L. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristoylation signal. J. Virol. 68 (1994) 6644-6654
26. Li H., Dou J., Ding L., and Spearman P. Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells. J. Virol. 81 (2007) 12899-12910
27. Ma Y.M., and Vogt V.M. Nucleic acid binding-induced Gag dimerization in the assembly of Rous sarcoma virus particles in vitro. J. Virol. 78 (2004) 52-60
28. Ono A., Demirov D., and Freed E.O. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. J. Virol. 74 (2000) 5142-5150
29. Ono A., Ablan S.D., Lockett S.J., Nagashima K., and Freed E.O. Phosphatidylinositol (4,5)-bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 14889-14894
30. Reil H., Bukovsky A.A., Gelderblom H.R., and Göttlinger H.G. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17 (1998) 2699-2708
31. Rhee S.S., and Hunter E. A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell 63 (1990) 77-86
32. Rhee S.S., Hui H.X., and Hunter E. Preassembled capsids of type D retroviruses contain a signal sufficient for targeting specifically to the plasma membrane. J. Virol. 64 (1990) 3844-3852
33. Rumlova-Klikova M., Hunter E., Nermut M.V., Pichova I., and Ruml T. Analysis of Mason-Pfizer monkey virus Gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape. J. Virol. 74 (2000) 8452-8459
34. Saad J.S., Miller J., Tai J., Kim A., Ghanam R.H., and Summers M.F. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 11364-11369
35. Saad J.S., Ablan S.D., Ghanam R.H., Kim A., Andrews K., Nagashima K., Soheilian F., Freed E.O., and Summers M.F. Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting. J. Mol. Biol. 382 (2008) 434-447
36. Sakalian M., and Hunter E. Separate assembly and transport domains within the Gag precursor of Mason-Pfizer monkey virus. J. Virol. 73 (1999) 8073-8082
37. Sakalian M., and Rapp N.D. Rescue of internal scaffold-deleted Mason-Pfizer monkey virus particle production by plasma membrane targeting. Virology 345 (2006) 317-327
38. Sakalian M., Dittmer S.S., Gandy A.D., Rapp N.D., Zábranský A., and Hunter E. The Mason-Pfizer monkey virus internal scaffold domain enables in vitro assembly of human immunodeficiency virus type 1 Gag. J. Virol. 76 (2002) 10811-10820
39. Sfakianos J.N., LaCasse R.A., and Hunter E. The M-PMV cytoplasmic targeting-retention signal directs nascent Gag polypeptides to a pericentriolar region of the cell. Traffic 4 (2003) 660-670
40. Smith G.H., and Lee B.K. Mouse mammary tumor virus polypeptide precursors in intracytoplasmic A particles. J. Natl. Cancer Inst. 55 (1975) 493-496
41. Smith G.H., and Wivel N.A. Intracytoplasmic A particles: mouse mammary tumor virus nucleoprotein cores?. J. Virol. 11 (1973) 575-584
42. Sommerfelt M.A., Rhee S.S., and Hunter E. Importance of p12 protein in Mason-Pfizer monkey virus assembly and infectivity. J. Virol. 66 (1992) 7005-7011
43. Ulbrich P., Haubova S., Nermut M.V., Hunter E., Rumlova M., and Ruml T. Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins. J. Virol. 80 (2006) 7089-7099
44. Vlach J., Lipov J., Rumlová M., Veverka V., Lang J., Srb P., Knejzlík Z., Pichová I., Hunter E., Hrabal R., and Ruml T. D-retrovirus morphogenetic switch driven by the targeting signal accessibility to Tctex-1 of dynein. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 10565-10570
45. von Schwedler U.K., Stray K.M., Hartus J.E., and Sundquist W.I. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 77 (2003) 5439-5450
46. Wright E.R., Schiller J.B., Ding H.J., Kieffer C., Fillmore C., Sundquist W.I., and Jensen G.J. Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J. 26 (2007) 2218-2226
47. Zábranský A., Hadravová R., Stokrová J., Sakalian M., and Pichová I. Premature processing of mouse mammary tumor virus Gag polyprotein impairs intracellular capsid assembly. Virology 384 (2009) 33-37
48. Zhang Y., Qian H., Love Z., and Barklis E. Analysis of the assembly function of the human immunodeficiency virus type 1 Gag protein nucleocapsid domain. J. Virol. 72 (1998) 1782-1789
49. Zimmerman C., Klein K.C., Kiser P.K., Singh A.R., Firestein B.L., Riba S.C., and Lingappa J.R. Identification of a host protein essential for assembly of immature HIV-1 capsids. Nature 415 (2002) 88-92